Morpholino

MO1-arfgef2

ID
ZDB-MRPHLNO-200221-1
Name
MO1-arfgef2
Previous Names
None
Target
Sequence
5' - TGAAGAAAAGGCTTACCTAGCGCCA - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-arfgef2
Expressed Gene Anatomy Figures
arfgef2 Fig. 5 from Lu et al., 2019
vegfaa Fig. 5 from Lu et al., 2019
Phenotype
Phenotype resulting from MO1-arfgef2
Phenotype Fish Figures
angioblast cell migration delayed, abnormal ci5Tg; y7Tg + MO1-arfgef2 Fig. 5 from Lu et al., 2019
heart tube straight, abnormal WT + MO1-arfgef2 Fig. S4 from Lu et al., 2019
intersegmental vessel incomplete structure, abnormal ci5Tg; y7Tg + MO1-arfgef2 Fig. 5,  Fig. 7 from Lu et al., 2019
intersegmental vessel angiogenesis decreased efficacy, abnormal y1Tg + MO1-arfgef2 Fig. 5,  Fig. 7 from Lu et al., 2019
pericardium edematous, abnormal WT + MO1-arfgef2 Fig. S4 from Lu et al., 2019
whole organism vegfaa expression decreased amount, abnormal WT + MO1-arfgef2 Fig. 5 from Lu et al., 2019
whole organism arfgef2 expression decreased amount, abnormal WT + MO1-arfgef2 Fig. 5 from Lu et al., 2019
Phenotype of all Fish created by or utilizing MO1-arfgef2
Phenotype Fish Conditions Figures
pericardium edematous, abnormal WT + MO1-arfgef2 standard conditions Fig. S4 from Lu et al., 2019
heart tube straight, abnormal WT + MO1-arfgef2 standard conditions Fig. S4 from Lu et al., 2019
whole organism vegfaa expression decreased amount, abnormal WT + MO1-arfgef2 standard conditions Fig. 5 from Lu et al., 2019
whole organism arfgef2 expression decreased amount, abnormal WT + MO1-arfgef2 standard conditions Fig. 5 from Lu et al., 2019
intersegmental vessel angiogenesis process efficacy, ameliorated y1Tg + MO1-arfgef2 chemical treatment: cobalt dichloride Fig. 7 from Lu et al., 2019
intersegmental vessel incomplete structure, abnormal y1Tg + MO1-arfgef2 control Fig. 7 from Lu et al., 2019
intersegmental vessel complete structure, ameliorated y1Tg + MO1-arfgef2 chemical treatment: cobalt dichloride Fig. 7 from Lu et al., 2019
intersegmental vessel angiogenesis decreased efficacy, abnormal y1Tg + MO1-arfgef2 control Fig. 7 from Lu et al., 2019
intersegmental vessel angiogenesis decreased efficacy, abnormal ci5Tg; y7Tg + MO1-arfgef2 standard conditions Fig. 5 from Lu et al., 2019
angioblast cell migration delayed, abnormal ci5Tg; y7Tg + MO1-arfgef2 standard conditions Fig. 5 from Lu et al., 2019
intersegmental vessel incomplete structure, abnormal ci5Tg; y7Tg + MO1-arfgef2 standard conditions Fig. 5 from Lu et al., 2019
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.